The Company's
second product, the MarrowSelect™, is currently being designed
to work in conjunction with the MarrowMiner®.
StemCor is currently
in the process of in-licensing several innovative technologies to
facilitate patient-side separation and fractionation of adult stem
cells from aspirated bone marrow using non-centrifugal methods.